logo
  

After-market Movers For May 4 (APC, THC, IM, CGNX, NUVA, ACRX, QLYS, RAIL)

Gainers:

Anadarko Petroleum Corp. (APC) was up one-tenths of a percent to $$93.85. The company's first quarter results were below Wall Street estimates. The company noted tht significant cost savings, outstanding well performance and ongoing efficiency gains enabled it to deliver higher sales volumes for lower costs.

Tenet Healthcare Corp. (THC) rose 2 percent to $50.50 after reporting first quarter results that topped analysts' expectations. The company also confirmed its existing outlook for 2015, in-line with Street view.

Ingram Micro Inc. (IM) was up 1 percent to $25.99. The company announced new $100 million cost savings plan and also decides to rsume its share buyback. The company's first quarter adjusted earnings per share missed Street view by a penny, while sales came above the consensus estimate.

Cognex Corp. (CGNX) rose 1 percent to $47.41 as its first quarter results topped Street view. The company also forecast second quarter revenue above Street view.

NuVasive, Inc. (NUVA) gained 5 percent to $47.99. The company swung to a profit in its first quarter and its adjusted earnings per share came above Street view. Sales for the quarter rose 8.4 percent and topped the consensus.

Decliners:

AcelRx Pharmaceuticals, Inc. (ACRX) plunged 26 percent to $3.08 following the company's disclosure that the FDA has denied the request for a Type B meeting and restated view that a clinical study is required for Zalviso.

Qualys, Inc. (QLYS) fell 27 percent to $40.01 as it forecast second quarter results below Street view and also lowered its 2015 revenue forecast. Meanwhile, the company swung to a profit in its first quarter on a GAAP basis and non-GAAP topped Wall Street view. Revenues for the quarter increased 24 percent, but missed the consensus estimate.

Trading halt:

Trading in shares of FreightCar America Inc. (RAIL) was halted. The company's first quarter results missed market view by a wider margin. The company noted that its first quarter revenues and profitability were adversely affected by a series of production line changeovers and inefficiencies, primarily at its Shoals facility, as well as weather disruptions.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.

Inflation data from the U.S. garnered maximum attention this week on the economics front, along with the interest rate decision by the European Central Bank. Read our stories to find out how these two key events are set to influence monetary policy in the months ahead. Other main news from the U.S. were the release of the minutes of the latest Fed policy session and the jobless claims data. Elsewhere, the interest rate decision by the Bank of Canada was also in focus.

View More Videos
Follow RTT